Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.

Journal of thrombosis and haemostasis : JTH - 1 Jan 2008

Grice G R, Milligan P E, Eby C, Gage B F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aryl Hydrocarbon Hydroxylases
Share to International Normalized Ratio
Share to Mixed Function Oxygenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Steroid Hydroxylases

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 17944998
DOI: 10.1111/j.1538-7836.2007.02797.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.PMID 17944998Read ↗

Pharmacogenetic-based dosing of warfarin.Semantic proximity Read ↗

Warfarin Pharmacogenetic Trials: Is there a Future for Pharmacogenetic-Guided Dosing?Semantic proximity Read ↗

Pharmacogenetics of warfarin: challenges and opportunitiesSemantic proximity Read ↗

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinSemantic proximity Read ↗

Pharmacogenetics in warfarin therapySemantic proximity Read ↗

Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.Semantic proximity Read ↗

Genotype-guided dosing of warfarin.Semantic proximity Read ↗

Warfarin pharmacogenetics: does more accurate dosing benefit patients?Semantic proximity Read ↗

Genetic and clinical factors relating to warfarin dosingSemantic proximity Read ↗

Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.Semantic proximity Read ↗

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.Semantic proximity Read ↗

Role of Warfarin Pharmacogenetic Testing in Clinical PracticeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.